Skip to main
PACS

PACS Stock Forecast & Price Target

PACS Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PACS Group is well-positioned in the growing and fragmented skilled nursing facility market, supported by a decentralized operating model and strategic technology assets. Its continued expansion, strong financial flexibility, and low leverage allow for potential opportunities in the thriving M&A market, while solid financial guidance and strong potential for earnings and revenue growth make it a promising investment. Potential risks include exposure to government reimbursements and labor costs, and there may be a negative impact due to regulatory challenges and potential financial restatements.

Bears say

PACS Group is focused on acquiring underperforming facilities and using a decentralized model to improve operations, which is a valid strategy given the fragmented market opportunity. However, the company's recent financial results and delays in reporting raise concerns about its execution and ability to turn around these facilities. Additionally, the high level of long-term care patients may contribute to lower profitability in the future despite the company's efforts.

PACS has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PACS Group, Inc. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PACS Group, Inc. (PACS) Forecast

Analysts have given PACS a Buy based on their latest research and market trends.

According to 5 analysts, PACS has a Buy consensus rating as of Jun 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $48, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $48, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PACS Group, Inc. (PACS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.